ESSENTIAL FATTY-ACID DEFICIENCY PREVENTS MULTIPLE LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN CD-1 MICE

被引：43
|
作者：
WRIGHT, JR
LEFKOWITH, JB
SCHREINER, G
LACY, PE
机构：
[1] WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1988年 / 85卷 / 16期
关键词：
D O I：
10.1073/pnas.85.16.6137
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：6137 / 6141
页数：5
相关论文
共 50 条
  • [1] ESSENTIAL FATTY-ACID DEFICIENCY PREVENTS MULTIPLE LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN NAIVE AND CYCLOSPORINE-TREATED LOW-RESPONDER MURINE STRAINS
    WRIGHT, JR
    FRASER, RB
    KAPOOR, S
    COOK, HW
    ACTA DIABETOLOGICA, 1995, 32 (02) : 125 - 130
  • [2] Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes
    Takamura, T
    Ando, H
    Nagai, Y
    Yamashita, H
    Nohara, E
    Kobayashi, K
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 44 (02) : 107 - 114
  • [3] Pioglitazone prevents mice from multiple low-dose Streptozotocin-induced insulitis and diabetes
    Ando, H
    Takamura, T
    Nagai, Y
    Yamashita, H
    Kobayashi, K
    DIABETOLOGIA, 1998, 41 : A160 - A160
  • [4] Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in Nonobese diabetic mice
    Rydgren, Tobias
    Vaarala, Outi
    Sandler, Stellan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01): : 180 - 185
  • [5] ABROGATION OF STREPTOZOTOCIN-INDUCED INSULITIS BY ESSENTIAL FATTY-ACID DEFICIENCY
    LEFKOWITH, JB
    WRIGHT, J
    LACY, P
    SCHREINER, GF
    CLINICAL RESEARCH, 1988, 36 (03): : A485 - A485
  • [6] INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE
    SANDBERG, JO
    ANDERSSON, A
    EIZIRIK, DL
    SANDLER, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (01) : 543 - 548
  • [7] IMMUNOMODULATION OF LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE
    GREULICH, B
    KIESEL, U
    GRIES, FA
    KOLB, H
    DIABETOLOGIA, 1982, 23 (02) : 171 - 171
  • [8] THE SUPPRESSIVE EFFECT OF ANTI-ASIALO GM1 ANTIBODY ON LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN CD-1 MICE
    MARUYAMA, T
    WATANABE, K
    YANAGAWA, T
    KASATANI, T
    KASUGA, A
    SHIMADA, A
    TAKEI, I
    SUZUKI, Y
    KATAOKA, K
    SARUTA, T
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1991, 16 (04): : 171 - 175
  • [9] The Protective Effects of CD39 Overexpression in Multiple Low-Dose Streptozotocin-Induced Diabetes in Mice
    Chia, Joanne S. J.
    McRae, Jennifer L.
    Thomas, Helen E.
    Fynch, Stacey
    Elkerbout, Lorraine
    Hill, Prue
    Murray-Segal, Lisa
    Robson, Simon C.
    Chen, Jiang-Fan
    d'Apice, Anthony J. F.
    Cowan, Peter J.
    Dwyer, Karen M.
    DIABETES, 2013, 62 (06) : 2026 - 2035
  • [10] EFFECTOR MECHANISMS IN LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE
    LUKIC, ML
    STOSIC, S
    OSTOJIC, N
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1993, 13 (01): : 91 - 92
12345